García-Layana, A. et al. Age Macular Degeneration: Etiology, Prevention, Individualized Therapies, Cell Therapy, and Tissue Engineering. Journal of Ophthalmology. January 2014.
Fernández-Robredo. et al. Current Treatment Limitations in Age-Related Macular Degeneration and Future Approaches Based on Cell Therapy and Tissue Engineering. Journal of Ophthalmology. January 2014.
Thumann et al. Engineering of PEDF-Expressing Primary Pigment Epithelial Cells by the SB Transposon System Delivered by pFAR4 Plasmids. Molecular Therapy Nucleic Acids. 2017. 6: 302-314.
Hudecek et al. Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side. Crit Rev Biochem Mol Biol. 2017. 12:1-26.
Stolba et al. Neovascular age-related macular degeneration in Austria – expert review and introduction to the TargetAMD approach. Spektrum der Augenheilkunde. 2017. 31: 206.
Garcia-Garcia L, et al. Long-Term PEDF Release in Rat Iris and Retinal Epithelial Cells after Sleeping Beauty Transposon-Mediated Gene Delivery. Molecular Therapy-Nucleic Acids. 2017. 9: 1-11
Pastor et al. The antibiotic-free pFAR4 vector paired with the Sleeping Beauty transposon system mediates efficient transgene delivery in human cells. Molecular Therapy-Nucleic Acids. 2018. 11: 57-67
Bakker et al. Small-scale GMP production of plasmid DNA using a simplified and fully disposable production method. Journal of Biotechnology: X 2. 2019. X 2:10007
Citable abstracts 2012-2017